In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes.
暂无分享,去创建一个
Nunzio Bottini | Stefano Bellucci | Andrea Magrini | Massimo Bottini | Nicola Rosato | N. Bottini | N. Rosato | S. Bellucci | A. Magrini | M. Bottini | Cristiano Sacchetti | Cristiano Sacchetti | Maurizio Mattei | Novella Rapini | Elisa Cirelli | Maurizio Mattei | N. Rapini | E. Cirelli
[1] Andrew Tsourkas,et al. Effect of ligand density, receptor density, and nanoparticle size on cell targeting. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[2] Stefano Bellucci,et al. Nanoparticles and Nanodevices in Biological Applications , 2009 .
[3] V. Kuchroo,et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.
[4] N. Bottini,et al. Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassemblies. , 2008, Journal of nanoscience and nanotechnology.
[5] V. C. Moore,et al. Band Gap Fluorescence from Individual Single-Walled Carbon Nanotubes , 2002, Science.
[6] A. Rudensky,et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. , 2005, Immunity.
[7] D. Scheinberg,et al. Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes. , 2008, Nano letters.
[8] Hongjie Dai,et al. Multiplexed multicolor Raman imaging of live cells with isotopically modified single walled carbon nanotubes. , 2008, Journal of the American Chemical Society.
[9] T. Whiteside. What are regulatory T cells (Treg) regulating in cancer and why? , 2012, Seminars in cancer biology.
[10] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[11] H. Dai,et al. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. , 2009, Journal of the American Chemical Society.
[12] M. Colombo,et al. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. , 2006, Cancer research.
[13] D. Mougiakakos,et al. Regulatory T cells in cancer. , 2010, Advances in cancer research.
[14] N. Zeps,et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] B. Chauffert,et al. Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4+CD25+ regulatory T cell proliferation , 2005, The Journal of experimental medicine.
[16] Yasuhiko Tabata,et al. Blood clearance and biodistribution of polymer brush-afforded silica particles prepared by surface-initiated living radical polymerization. , 2012, Biomacromolecules.
[17] N. Bottini,et al. Carbon nanotube-based nanocarriers: the importance of keeping it clean. , 2010, Journal of nanoscience and nanotechnology.
[18] L. Terracciano,et al. High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients , 2010, International journal of cancer.
[19] M. Prato,et al. Targeting carbon nanotubes against cancer. , 2012, Chemical communications.
[20] Weibo Cai,et al. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.
[21] J. Shimizu,et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.
[22] Bing Yan,et al. Endosomal leakage and nuclear translocation of multiwalled carbon nanotubes: developing a model for cell uptake. , 2009, Nano letters.
[23] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[24] Stanislaus S. Wong,et al. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. , 2008, Journal of the American Chemical Society.
[25] E. Jaffee,et al. Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response , 2005, The Journal of experimental medicine.
[26] H. Levitsky,et al. Natural Regulatory T Cells and De Novo-Induced Regulatory T Cells Contribute Independently to Tumor-Specific Tolerance1 , 2007, The Journal of Immunology.
[27] S. Sakaguchi,et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. , 2007, Immunity.
[28] D. Scheinberg,et al. Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes , 2007, Journal of Nuclear Medicine.
[29] Omar K. Yaghi,et al. In vivo fluorescence imaging in the second near-infrared window with long circulating carbon nanotubes capable of ultrahigh tumor uptake. , 2012, Journal of the American Chemical Society.
[30] Zhuang Liu,et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.
[31] Nunzio Bottini,et al. Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. , 2013, ACS nano.
[32] Nicholas Melosh,et al. Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. , 2012, Nano letters.
[33] R K Jain,et al. Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.
[34] Sanjiv S Gambhir,et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. , 2008, Nature nanotechnology.
[35] G. Dranoff,et al. Combining immunotherapy and targeted therapies in cancer treatment , 2012, Nature Reviews Cancer.
[36] Hari Singh Nalwa,et al. Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs. , 2011, Journal of biomedical nanotechnology.
[37] F. Toma,et al. Degree of chemical functionalization of carbon nanotubes determines tissue distribution and excretion profile. , 2012, Angewandte Chemie.
[38] M. Colombo,et al. Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy , 2007, Nature Reviews Cancer.
[39] J. Ellwart,et al. CD103 is a hallmark of tumor‐infiltrating regulatory T cells , 2011, International journal of cancer.
[40] Nunzio Bottini,et al. PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead. , 2011, Biomacromolecules.
[41] Zhuang Liu,et al. A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. , 2009, Nature nanotechnology.
[42] V. Muzykantov,et al. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities , 2012, Science.